Subscribe to our professional mailing list

Join 15,000 of your fellow colleagues today!
* indicates required
Email Format: or

Archives for Neuropsychiatry

Current News & Research

Psychiatry’s Solid Center

“Psychiatric disorders result from the complex interaction of physical, psychological and social factors and treatment may be directed toward any or all three of these #8221; –Official Position of the American Psychiatric Association, 1978 If you invite the wrong group of psychiatrists to a...
Continue Reading

Carlat Psychiatry Report

Cognitive Deficits in Schizophrenia

Lately, you’ve probably seen a lot of articles in the journals (not to mention in the journal ads) about targeting cognition in schizophrenia. Latuda (lurasidone), the latest FDA approved antipsychotic, is being talked up to have “pro-cognitive” effects—whatever that means. (See accompanying article by...
Continue Reading


Research Updates in Psychiatry

ATYPICAL ANTIPYSCHOTICS strong>Abilify for Depression and Bipolar Disorder: A Meta-Analysis Abilify (aripiprazole), which has long been FDA-approved for both schizophrenia and manic episodes of bipolar disorder, was recently approved for augmentation of antidepressants in patients with treatment-resistant depression. But there has been controversy about...
Continue Reading

Carlat Psychiatry Report

Vagus Nerve Stimulation: A Brief Update

VNS (vagus nerve stimulation) was initially developed and approved for treatment-refractory epilepsy. Cyberonics conducted one sham-controlled study for treatment-resistant depression, and while this double-blind study showed no statistical benefit over placebo, an open-label extension showed enough benefit to impress someone at the FDA. In...
Continue Reading